Recruiting now
-
ROMANCE: “Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer”
Phase 2 · randomised · 150 people · 26 sites in Italy · Recruiting now
-
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Not phased · randomised · 84 people · 1 site in Greece · Recruiting now
-
Neoadjuvant Radiotherapy vs Upfront Surgery in Locally Advanced Proximal Rectal Cancer
Not phased · randomised · 100 people · 1 site in Turkey (Türkiye) · Recruiting now
-
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
Phase 2 · 16 people · 1 site in United States · Recruiting now
-
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Phase 2 · 180 people · 1 site in China · Recruiting now